FDAnews
www.fdanews.com/articles/176787-correction

Correction

May 24, 2016

An item in yesterday’s Device Daily Bulletin incorrectly listed what Cerus’ Intercept blood system was approved for. It received approval for the ex vivo preparation of whole blood-derived and apheresis plasma to minimize the risk of transfusion-transmitted infections.

 

View More Stories